Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07538570 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Pain Treatment After Total Knee Arthroplasty

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Vertex Pharmaceuticals

Record History

  1. Primary endpoint(s) modifiedv3 See this version in full on ClinicalTrials.gov ↗
  2. Recruitment opened Study sites: 0 to 2 · Start date changed from estimate of Apr 22, 2026 to Apr 24, 2026v2 Show 2 more changesShow less
    • Study sites: 0 to 2
    • Start date changed from estimate of Apr 22, 2026 to Apr 24, 2026
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Trial Details
NCT Number NCT07538570
Lead Sponsor Vertex Pharmaceuticals Incorporated
Conditions Pain
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov